tiprankstipranks
Aurora Labs Ltd. (AU:A3D)
ASX:A3D
Want to see AU:A3D full AI Analyst Report?

Aurora Labs (A3D) AI Stock Analysis

8 Followers

Top Page

AU:A3D

Aurora Labs

(Sydney:A3D)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 5.2)
Rating:50Neutral
Price Target:
AU$0.05
▼(-16.67% Downside)
Action:Reiterated
Date:02/13/26
The score is held back primarily by weak financial quality—ongoing losses, negative operating cash flow, and higher leverage—despite strong top-line growth. Technicals are a meaningful offset, with price and momentum indicators signaling a solid uptrend. Valuation remains constrained because the company is loss-making (negative P/E) and no dividend yield is provided.
Positive Factors
Strong Revenue Growth
Sustained 183.75% revenue growth demonstrates accelerating demand and market traction for Aurora Labs' products. Over a 2–6 month horizon this growth underpins scale economics, helps spread fixed costs, and provides runway to invest in R&D and commercialization to reach profitability.
Negative Factors
Persistent Unprofitability
Ongoing negative net and EBIT margins indicate the business still fails to cover operating costs from current revenues. Over the coming months this persistent unprofitability constrains reinvestment, increases dependence on external funding, and delays when scale will deliver consistent positive earnings.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Sustained 183.75% revenue growth demonstrates accelerating demand and market traction for Aurora Labs' products. Over a 2–6 month horizon this growth underpins scale economics, helps spread fixed costs, and provides runway to invest in R&D and commercialization to reach profitability.
Read all positive factors

Aurora Labs (A3D) vs. iShares MSCI Australia ETF (EWA)

Aurora Labs Business Overview & Revenue Model

Company Description
Established in 2014 and headquartered in Canning Vale, Australia, Aurora Labs Limited specializes in the creation, enhancement, and market introduction of 3D metal printers, along with complementary powders, digital components, and relevant intell...
How the Company Makes Money
null...

Aurora Labs Financial Statement Overview

Summary
Very strong revenue growth (183.75%) and improved gross margin (43.91%) are positives, but profitability remains weak (negative net and EBIT margins) with ongoing losses. Cash flow is pressured by negative operating cash flow and only modest free cash flow growth, while leverage has risen (debt-to-equity 0.89), increasing financial risk.
Income Statement
35
Negative
Balance Sheet
40
Negative
Cash Flow
30
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue708.31K743.83K174.30K134.56K32.20K171.62K
Gross Profit-1.37M326.65K57.13K58.81K13.89K-145.00K
EBITDA-4.77M-4.54M-3.23M-3.37M-3.70M-4.81M
Net Income-4.05M-3.75M-2.81M-2.96M-3.15M-4.42M
Balance Sheet
Total Assets5.77M2.91M3.08M2.18M3.35M2.91M
Cash, Cash Equivalents and Short-Term Investments3.65M1.16M1.65M986.80K1.95M1.37M
Total Debt232.00K956.01K842.94K65.39K160.53K252.00K
Total Liabilities1.40M1.84M1.30M719.35K716.58K711.20K
Stockholders Equity4.37M1.07M1.78M1.46M2.63M2.20M
Cash Flow
Free Cash Flow-4.21M-2.80M-2.41M-2.60M-2.68M-1.68M
Operating Cash Flow-3.22M-2.62M-2.40M-2.57M-2.63M-1.68M
Investing Cash Flow-988.63K-180.58K-7.69K-23.07K-48.42K6.86K
Financing Cash Flow5.68M2.31M3.07M1.63M3.25M1.72M

Aurora Labs Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.06
Price Trends
50DMA
0.05
Negative
100DMA
0.05
Negative
200DMA
0.05
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
42.69
Neutral
STOCH
15.74
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:A3D, the sentiment is Negative. The current price of 0.06 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and above the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 42.69 is Neutral, neither overbought nor oversold. The STOCH value of 15.74 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:A3D.

Aurora Labs Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
AU$60.47M12.4412.00%1.92%9.98%70.40%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
50
Neutral
AU$26.18M-5.32-148.94%170.20%4.95%
41
Neutral
AU$353.66M-10.87-99.54%13.94%-84.03%
41
Neutral
AU$83.48M-8.83-29.37%-42.46%-64.36%
40
Underperform
AU$303.14M-31.93-68.32%-9.99%-245.74%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:A3D
Aurora Labs
0.05
<0.01
11.11%
AU:TTT
Titomic Ltd
0.22
-0.06
-22.81%
AU:AL3
AML3D Ltd
0.15
>-0.01
-3.23%
AU:MPW
Metal Powder Works Limited
2.02
0.56
38.36%
AU:LBL
Laserbond Limited
0.51
0.16
44.07%

Aurora Labs Corporate Events

Aurora Labs Wins A$1m Defence Grant to Scale 3D-Printed Turbine Production
Jun 1, 2026
Aurora Labs has secured a A$1 million Defence Industry Development Grant from the Australian Government, which it will match for a A$2 million co-investment to buy and commission a large-format commercial metal 3D printer at its Canning Vale facil...
Aurora Labs Deepens Defence Push as Propulsion Pipeline and Manufacturing Capacity Grow
Apr 22, 2026
Aurora Labs reported continued progress in commercialising its metal additive manufacturing and turbojet propulsion technologies during the March quarter, driven by defence-aligned initiatives and growing international engagement. The company adva...
Aurora Labs Grants 2.5 Million Unlisted Options to Director
Apr 10, 2026
Aurora Labs Limited has reported a change in the securities held by director Andrew Bottrell, reflecting the issuance of new unlisted director options rather than any on-market trading activity.Following shareholder approval on 9 April 2026, Bottr...
Aurora Labs Issues New Option Package to Director Rebekah Letheby
Apr 10, 2026
Aurora Labs has disclosed a change in director Rebekah Letheby&#8217;s interests following the issue of 7.5 million unlisted director options. The options, approved by shareholders on 9 April 2026, are exercisable at $0.14 each before 10 April 202...
Aurora Labs Grants Additional Unlisted Options to Director
Apr 10, 2026
Aurora Labs has reported a change in director Andrew Garth&#8217;s interests, following shareholder approval for the issue of additional unlisted director options. The filing details that Garth has been granted 7,500,000 unlisted options exercisab...
Aurora Labs Issues 25 Million Unquoted Director Options
Apr 10, 2026
Aurora Labs Limited has notified the market of the issue of 25 million unquoted Director Options, dated 10 April 2026, under an Appendix 3G filing to the ASX. The options, which form part of a previously announced transaction and are not intended ...
Aurora Labs Strengthens Governance With New Company Secretary
Apr 1, 2026
Aurora Labs has announced a change in its company secretary, with Grant Mooney resigning effective 10 April 2026 and Stephen Buckley stepping into the role. Buckley, a director at Governance Corporate, brings more than four decades of financial ma...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 13, 2026